Effects of ibandronate on bone quality: Preclinical studies
- 28 February 2007
- journal article
- review article
- Published by Elsevier BV in Bone
- Vol. 40 (2), 265-273
- https://doi.org/10.1016/j.bone.2006.08.002
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- High dosage treatment of nitrogen-containing bisphosphonate ibandronate is required for osseointegration of cementless metal implantsJournal of Orthopaedic Science, 2005
- Revival of Bone Strength: The Bottom LineJournal of Bone and Mineral Research, 2005
- Intermittent Ibandronate Preserves Bone Quality and Bone Strength in the Lumbar Spine After 16 Months of Treatment in the Ovariectomized Cynomolgus MonkeyJournal of Bone and Mineral Research, 2004
- Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal OsteoporosisJournal of Bone and Mineral Research, 2004
- Efficacy and safety of ibandronate given by intravenous injection once every 3 monthsBone, 2004
- Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosisBone, 2004
- Intermittent and Continuous Administration of the Bisphosphonate Ibandronate in Ovariohysterectomized Beagle Dogs: Effects on Bone Morphometry and Mineral PropertiesJournal of Bone and Mineral Research, 1999
- Intermittent cyclical etidronate treatment maintains the mass, structure and the mechanical property of bone in ovariectomized ratsJournal of Bone and Mineral Research, 1995
- A new bisphosphonate, BM 21.0955, prevents bone loss associated with cessation of ovarian function in experimental dogsJournal of Bone and Mineral Research, 1993
- Continuous alendronate treatment throughout growth, maturation, and aging in the rat results in increases in bone mass and mechanical propertiesCalcified Tissue International, 1993